EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitScoping Review

Economics of dementia care across five developed countries: A scoping review

Zoe C Gurney, Shusei Yokota iD, Angelina-Jessica Vita iD, Joshua Jargowsky iD, Gregory D Shumer iD, Hai Fang, Elham Mahmoudi iD

Journal of Alzheimer’s Disease · 14.11.2026

DOI: 10.1177/13872877261505501 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 14.11.2026. Verfasst von Zoe C Gurney und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, University of Michigan Medical School, Ann Arbor, MI, USA. Die Arbeit nennt 96 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

As the global population ages, the number of people living with dementia is rising rapidly, creating substantial economic challenges for healthcare systems, caregivers, and societies worldwide.

Objective

We examined the economics of dementia care across five developed countries to identify potentially transferable care practices and policy approaches relevant to the U.S.

Methods

We conducted a scoping review of studies involving adults with dementia that assessed dementia care, healthcare utilization, or costs in Canada, France, Germany, China, and Japan. Searches were performed in Ovid MEDLINE and Ovid Embase for January 2017–December 2023.

Results

Of 12,286 titles and abstracts screened, 266 articles underwent full-text review, and 63 met inclusion criteria. Studies were categorized into three areas: prescription drug use, direct medical costs, and economic impacts of care models or policies. We found that use of antidementia medications generally decreases with increasing dementia severity. Higher severity and greater burden of comorbidity were associated with increased costs, largely driven by frequent hospitalizations and long-term care. Policies incentivizing informal caregiving were associated with delayed long-term care but may reduce caregivers’ labor-force participation, while in-kind, service-based models showed more consistent evidence of delaying costly institutional care. Evidence on integrated care models was mixed.

Conclusions

Rising dementia-related healthcare costs in aging populations represent a shared global challenge. Aligning reimbursement policies, care models, and service delivery with disease severity and care needs can improve efficiency, equity, and sustainability.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer's diseasedementia carehealthcare costshealthcare useprescription drug

Autor:innen und Institutionen

  • Department of Family Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Institute for Healthcare Policy and Innovation, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Pharmaceutical Sciences Department, University of Michigan College of Pharmacy, Ann Arbor, MI, USA.
  • China Center for Health Development Studies, Peking University, Beijing, China.

ORCID-Profile: Shusei Yokota, Angelina-Jessica Vita, Joshua Jargowsky, Gregory D Shumer, Elham Mahmoudi

Zitieren

APA

Gurney, Z. C., Yokota, S., Vita, A. J., Jargowsky, J., Shumer, G. D., Fang, H., & Mahmoudi, E. (2026). Economics of dementia care across five developed countries: A scoping review. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877261505501

Vancouver

Gurney ZC, Yokota S, Vita AJ, Jargowsky J, Shumer GD, Fang H, et al. Economics of dementia care across five developed countries: A scoping review. Journal of Alzheimer’s Disease. 2026. doi:10.1177/13872877261505501

BibTeX
@article{Gurney2026,
  author = {Gurney, Zoe C and Yokota, Shusei and Vita, Angelina-Jessica and Jargowsky, Joshua and Shumer, Gregory D and Fang, Hai and Mahmoudi, Elham},
  title = {Economics of dementia care across five developed countries: A scoping review},
  journal = {Journal of Alzheimer’s Disease},
  year = {2026},
  doi = {10.1177/13872877261505501}
}
Kostenlos starten →